Tolerability of atypical neuroleptics and acetylcholinesterase inhibitors when treating neuropsychiatric symptoms in Parkinson's disease
Journal of Parkinsonism and Restless Legs Syndrome · 2012
DOI: 10.2147/jprls.s37450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Parkinsonism and Restless Legs Syndrome, 2012. Verfasst von Christopher Tolleson und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tolleson, C., Fang, J., Lu, P., Wu, H., & Davis, T. (2012). Tolerability of atypical neuroleptics and acetylcholinesterase inhibitors when treating neuropsychiatric symptoms in Parkinson's disease. Journal of Parkinsonism and Restless Legs Syndrome. https://doi.org/10.2147/jprls.s37450
Vancouver
Tolleson C, Fang J, Lu P, Wu H, Davis T. Tolerability of atypical neuroleptics and acetylcholinesterase inhibitors when treating neuropsychiatric symptoms in Parkinson's disease. Journal of Parkinsonism and Restless Legs Syndrome. 2012. doi:10.2147/jprls.s37450
BibTeX
@article{Tolleson2012,
author = {Tolleson, Christopher and Fang, John and Lu, Pengcheng and Wu, Huiyun and Davis, Thomas},
title = {Tolerability of atypical neuroleptics and acetylcholinesterase inhibitors when treating neuropsychiatric symptoms in Parkinson's disease},
journal = {Journal of Parkinsonism and Restless Legs Syndrome},
year = {2012},
doi = {10.2147/jprls.s37450}
}
EUVIMED